当前位置:首页 - 行情中心 - 柳药集团(603368) - 财务分析

柳药集团

(603368)

  

流通市值:66.73亿  总市值:66.73亿
流通股本:3.97亿   总股本:3.97亿

柳药集团(603368)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.25亿元,每股收益0.64元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益831431.05万元,未分配利润515509.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2081826.26万元,负债1250395.21万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入5,377,272,243.6520,926,270,790.415,758,036,706.0110,300,787,773.83
营业总成本5,065,165,311.0820,015,831,005.5114,995,915,128.079,788,688,628.19
其他经营收益
营业利润275,808,800.3882,385,074.27754,347,468.11505,036,476.16
利润总额273,142,798.85869,941,726.73748,512,238.63499,039,943.11
净利润225,454,168.92720,536,392.03653,956,241.67438,387,532.04
每股收益
其他综合收益----
综合收益总额225,454,168.92720,536,392.03653,956,241.67438,387,532.04
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计17,888,527,587.9218,426,676,239.0718,254,424,698.9318,485,169,091.04
非流动资产:
非流动资产合计2,929,735,019.252,911,389,588.722,929,476,645.232,678,256,522.09
资产总计20,818,262,607.1721,338,065,827.7921,183,901,344.1621,163,425,613.13
流动负债:
流动负债合计11,176,884,107.812,220,977,439.511,156,630,426.0911,367,199,123.76
非流动负债:
非流动负债合计1,327,067,955.83975,050,345.31,890,186,861.171,717,654,733.66
负债合计12,503,952,063.6313,196,027,784.813,046,817,287.2613,084,853,857.42
所有者权益(或股东权益):
归属于母公司股东权益合计8,006,108,912.947,828,896,148.077,824,897,722.617,756,951,998.17
股东权益合计8,314,310,543.548,142,038,042.998,137,084,056.98,078,571,755.71
负债和股东权益合计20,818,262,607.1721,338,065,827.7921,183,901,344.1621,163,425,613.13
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计5,411,428,806.0224,173,987,512.8717,966,940,066.3412,240,812,179.58
经营活动现金流出小计5,920,580,373.1123,096,328,583.5117,831,550,396.3512,152,378,764.21
经营活动产生的现金流量净额-509,151,567.091,077,658,929.36135,389,669.9988,433,415.37
投资活动产生的现金流量:
投资活动现金流入小计225,023,841.91,245,182,145.33489,039,558.78488,285,390.21
投资活动现金流出小计374,637,444.021,747,027,537.451,090,653,512.49803,858,179.46
投资活动产生的现金流量净额-149,613,602.12-501,845,392.12-601,613,953.71-315,572,789.25
筹资活动产生的现金流量:
筹资活动现金流入小计2,087,769,468.856,592,259,050.323,630,714,588.542,353,449,673.71
筹资活动现金流出小计2,970,245,908.197,224,325,936.374,910,043,840.253,378,668,206.71
筹资活动产生的现金流量净额-882,476,439.34-632,066,886.05-1,279,329,251.71-1,025,218,533
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,541,241,608.55-56,253,348.81-1,745,553,535.43-1,252,357,906.88
期末现金及现金等价物余额1,801,066,106.863,342,307,715.411,653,007,528.792,146,203,157.34
补充资料:
现金及现金等价物的净增加额--56,253,348.81--1,252,357,906.88
最新报告期:2026-05-02
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华泰证券代雯,孔垂岩,王殷杰1.711.781.882026-05-02
TOP↑